In-house conventional RT-PCR |
Faye et al., 2008 (16) |
1 |
|
Balm et al., 2012 (17) |
1 |
|
Moureau et al., 2007 (18) |
1 |
|
Patel et al., 2013 (19) |
1 |
|
Own design |
1 |
|
Scaramozzino et al., 2001 (20) |
3 |
In-house quantitative real-time RT-PCR (no. of RNA copies/ml) |
Corman et al., 2016 (21) |
3 |
Real-time RT-PCR (CT value) |
|
|
In-house |
Corman et al., 2016 (21) |
3 |
|
Faye et al., 2013 (22) |
13 |
|
Lanciotti et al., 2008 (2) |
17 |
|
Pyke et al., 2014 (23) |
1 |
|
Tappe et al., 2014 (24) |
1 |
|
Own design |
8 |
|
CDC Trioplex (25) |
4 |
Commercial |
Altona (26) |
16 |
|
Clonit (27) |
1 |
|
Fast Track Diagnostics (28) |
1 |
|
Genesig (29) |
1 |
|
Liferiver (30) |
2 |
|
Roche (31) |
2 |
|
Sacace Biotechnologies (32) |
1 |
In-house RT–loop-mediated isothermal amplification (time [in minutes]) |
Own design |
3 |